MihaiMititeluMD MPH FASRS

Ophthalmology • Madison, WI

Retinal Disease

Associate Professor, Medical Director Clinical Eye Research Unit (CERU)

Join to view full profile

Dr. Mititelu is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Mititelu's full profile

Already have an account?

Office
2880 University Ave
Madison, WI 53705
Phone+1 608-263-7171

Fax+1 608-265-8060

Education & Training

Northwestern University McGaw Medical CenterDiseases of the Retina and Vitreous Fellowship, 2012 - 2013
Zucker School of Medicine at Hofstra/NorthwellOphthalmology Chief Resident, 2011 - 2012
Zucker School of Medicine at Hofstra/NorthwellResidency, Ophthalmology, 2009 - 2012
UPMC Medical EducationInternship, Transitional Year, 2008 - 2009
Wake Forest School of Medicine of Wake Forest Baptist Medical CenterClass of 2008
Duke UniversityBS, Cum Laude, 1999 - 2003
Tulane UniversityMPH

Certifications & Licensure

IL State Medical License 2012 - 2026
WI State Medical License 2013 - 2025
NY State Medical License 2009 - 2013
PA State Medical License 2008 - 2010
American Board of Ophthalmology Ophthalmology

Awards, Honors, & Recognition

Fellow American Academy of Ophthalmology (AAO)
Fellow American Society of Retina Specialists (ASRS), 2022

Clinical Trials

Bevacizumab Against Recurrent Retinal Detachment Start of enrollment: 2015 Jan 21
Completed
Phase 2
Control of Pain in Intravitreal Injections Using Topical NSAIDs Start of enrollment: 2019 Jun 27
Completed
Phase 4
Study of Pegcetacoplan (APL-2) Therapy in Patients With Geographic Atrophy Start of enrollment: 2015 Sep 24
Completed
Phase 2
An Extension Study to Evaluate the Long-term Safety and Efficacy of Pegcetacoplan (APL-2) in Subjects With Geographic Atrophy Secondary to AMD Start of enrollment: 2021 Mar 04
Active, not recruiting
Phase 3
Study of the Effects of High Dose Aflibercept Injected Into the Eye of Patients With an Age-related Disorder That Causes Loss of Vision Due to Growth of Abnormal Blood Vessels at the Back of the Eye Start of enrollment: 2020 Aug 11
Active, not recruiting
Phase 3
An Observational Study of the Progression of Intermediate Age-Related Macular Degeneration Start of enrollment: 2022 May 27
Recruiting
A Clinical Effectiveness Study Examining the Efficacy and Safety of ONS-5010 in Subjects With Neovascular Age-related Macular Degeneration (AMD) Start of enrollment: 2018 Oct 01
Completed
Phase 3
Phase 1 Study of Topical Ocular PAN-90806 for Neovascular AMD Start of enrollment: 2014 Feb 01
Completed
Phase 1
TODAY2 Phase 2 Follow-up Start of enrollment: 2014 Mar 01
Completed
Whole Eye Optical Coherence Tomography (OCT) to Improve Refractive Surgery and Eye Care Start of enrollment: 2014 Oct 09
Terminated
Comparison of Age-related Macular Degeneration Treatments Trials: Lucentis-Avastin Trial Start of enrollment: 2008 Feb 01
Completed
Phase 3
AMD Ryan Initiative Study (ARIS) Start of enrollment: 2018 Feb 12
Completed
A Study to Learn How Well a Higher Amount of Aflibercept Given as an Injection Into the Eye Works and How Safe it is in People With Reduced Vision Due to Swelling in the Macula, Central Part of the Retina Caused by a Blocked Vein in the Retina (Macula Edema Secondary to Retinal Vein Occlusion) Start of enrollment: 2023 May 15
Recruiting
Phase 3
Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis Start of enrollment: 2022 Aug 23
Active, not recruiting
Phase 2
A Randomized, Double-Blind, Placebo-Controlled Trial of IkT-148009 in Untreated Parkinson's Disease Start of enrollment: 2023 May 15
Active, not recruiting
Phase 2
Retinal Fundus Flavoprotein Fluorescence in Age Related Macular Degeneration Start of enrollment: 2024 Apr 16
Recruiting
Not Applicable
Join now to see all

Publications & Presentations

PubMed

9 citations
New method for risk assessment in environmental health: The paradigm of heavy metals in honey.
Magdalena Mititelu, Denisa Ioana Udeanu, Anca Oana Docea, Aristidis Tsatsakis, Daniela Calina
Environmental Research. 2023-11-01
Peripheral Exudative Hemorrhagic Chorioretinopathy (PEHCR): Diagnostic and Therapeutic Challenges.
Kevin F Elwood, Paige J Richards, Kathleen R Schildroth, Mihai Mititelu
Medicina. 2023-08-22
6 citations
Retinal Thickness and Morphology Changes on OCT in Youth with Type 2 Diabetes: Findings from the TODAY Study.
Mihai Mititelu, Diane Uschner, Lindsay Doherty, Petter Bjornstad, Amitha Domalpally
Ophthalmology Science. 2022-12-01

Journal Articles

Familial Exudative Vitreoretinopathy (EyeNet Magazine, AAO)
Konda SM, Bowen RC, Chang JS, Mititelu M, EyeNet Magazine AAO, 11/1/2019
Disorganization of Retinal Inner Layers in Retinal Vein Occlusions: New Insights From Anti-VEGF Treatment(JVRD, ASRS)
Minh T. Nguyen, MD, Aline L.B. Martins, MD, Mia A. Heiligenstein, BS, Barbara A. Blodi, MD, Mihai Mititelu, MD, MPH, Journal of VitreoRetinal Diseases, 2/12/2019
Autoimmune Retinopathy: Diagnosis and Management (EyeNet Magazine, AAO)
Khanna S, Ringeisen A, Mititelu M, EyeNet Magazine AAO, 9/1/2017
Case Series of Anti-Vascular Endothelial Growth Factor and Photodynamic Therapy in the Treatment of Circumscribed Choroidal Hemangiomas (JVRD, ASRS)
Han Kim, MD, Angeline Wang, MD, Mihai Mititelu, MD, MPH, Journal of VitreoRetinal Diseases, 2/1/2017
Join now to see all